 | • レポートコード：20QY06-01212 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、オキサリプラチンのグローバル市場について種類別（マンニトール、ブドウ糖液、乳糖液、その他）、用途別（大腸癌、胃癌、卵巣癌、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・オキサリプラチン市場の概要 ・世界の主要地域別オキサリプラチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のオキサリプラチン市場規模2015-2026：種類別（マンニトール、ブドウ糖液、乳糖液、その他） ・世界のオキサリプラチン市場規模2015-2026：用途別（大腸癌、胃癌、卵巣癌、その他） ・オキサリプラチンの北米市場規模2015-2020 ・オキサリプラチンのヨーロッパ市場規模2015-2020 ・オキサリプラチンの中国市場規模2015-2020 ・オキサリプラチンの日本市場規模2015-2020 ・オキサリプラチンの東南アジア市場規模2015-2020 ・オキサリプラチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi-Aventis、Yakult honsha、Dr Reddy's laboratories、Sun Pharmaceutical、Teva、Fresenius Kabi、Hospira、Mylan、Jiangsu Hengrui Medicine、Nanjing Pharmaceutical Factory、Jiangsu Aosaikang Pharmaceutical、Qilu Pharmaceutical、Hisun Pharmaceutical、Lunan Pharmaceutical、Luoxin、Halfsky Pharmacy、YRPG、Hainan Jinrui Pharmaceutical、Jari Pharmaceutical、Chiatai Tianqing） ・オキサリプラチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・オキサリプラチンの市場動向・機会・課題 ・調査の結論 |
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
The Oxaliplatin concentration is high; there are many manufacturers in the world, and high-end products mainly from USA and Europe. In the world wide, giant manufactures mainly distribute in US, Europe and China such as Sanofi-Aventis, Yakult honsha, Dr Reddy’s laboratories, Teva and Jiangsu Hengrui Medicine.
Market Analysis and Insights: Global Oxaliplatin Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oxaliplatin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oxaliplatin industry.
Based on our recent survey, we have several different scenarios about the Oxaliplatin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 848.8 million in 2019. The market size of Oxaliplatin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Oxaliplatin Scope and Market Size
The global Oxaliplatin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oxaliplatin market is segmented into
Mannitol
Glucose Solution
Lactose Solution
Other
Segment by Application, the Oxaliplatin market is segmented into
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Other
The Oxaliplatin market is analysed and market size information is provided by regions (countries). Segment by Application, the Oxaliplatin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oxaliplatin Market Share Analysis
Oxaliplatin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oxaliplatin business, the date to enter into the Oxaliplatin market, Oxaliplatin product introduction, recent developments, etc.
The major vendors covered:
Sanofi-Aventis
Yakult honsha
Dr Reddy’s laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing
1 Oxaliplatin Market Overview
1.1 Oxaliplatin Product Scope
1.2 Oxaliplatin Segment by Type
1.2.1 Global Oxaliplatin Sales by Type (2020-2026)
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Other
1.3 Oxaliplatin Segment by Application
1.3.1 Global Oxaliplatin Sales Comparison by Application (2020-2026)
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Other
1.4 Oxaliplatin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oxaliplatin Sales Growth Rate (2015-2026)
1.4.2 Global Oxaliplatin Revenue and Growth Rate (2015-2026)
1.4.3 Global Oxaliplatin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Oxaliplatin Industry Impact
1.5.1 How the Covid-19 is Affecting the Oxaliplatin Industry
1.5.1.1 Oxaliplatin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Oxaliplatin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Oxaliplatin Players to Combat Covid-19 Impact
2 Oxaliplatin Estimate and Forecast by Region
2.1 Global Oxaliplatin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oxaliplatin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oxaliplatin Sales Market Share by Region (2015-2020)
2.2.2 Global Oxaliplatin Revenue Market Share by Region (2015-2020)
2.3 Global Oxaliplatin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oxaliplatin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oxaliplatin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oxaliplatin Estimates and Projections (2015-2026)
2.4.2 Europe Oxaliplatin Estimates and Projections (2015-2026)
2.4.3 China Oxaliplatin Estimates and Projections (2015-2026)
2.4.4 Japan Oxaliplatin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oxaliplatin Estimates and Projections (2015-2026)
2.4.6 India Oxaliplatin Estimates and Projections (2015-2026)
3 Global Oxaliplatin Competition Landscape by Players
3.1 Global Top Oxaliplatin Players by Sales (2015-2020)
3.2 Global Top Oxaliplatin Players by Revenue (2015-2020)
3.3 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2019)
3.4 Global Oxaliplatin Average Price by Company (2015-2020)
3.5 Manufacturers Oxaliplatin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oxaliplatin Players (Opinion Leaders)
4 Global Oxaliplatin Market Size by Type
4.1 Global Oxaliplatin Historic Market Review by Type (2015-2020)
4.1.1 Global Oxaliplatin Sales Market Share by Type (2015-2020)
4.1.2 Global Oxaliplatin Revenue Market Share by Type (2015-2020)
4.1.3 Global Oxaliplatin Price by Type (2014-2020)
4.2 Global Oxaliplatin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oxaliplatin Sales Forecast by Type (2021-2026)
4.2.2 Global Oxaliplatin Revenue Forecast by Type (2021-2026)
4.2.3 Global Oxaliplatin Price Forecast by Type (2021-2026)
5 Global Oxaliplatin Market Size by Application
5.1 Global Oxaliplatin Historic Market Review by Application (2015-2020)
5.1.1 Global Oxaliplatin Sales Market Share by Application (2015-2020)
5.1.2 Global Oxaliplatin Revenue Market Share by Application (2015-2020)
5.1.3 Global Oxaliplatin Price by Application (2015-2020)
5.2 Global Oxaliplatin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oxaliplatin Sales Forecast by Application (2021-2026)
5.2.2 Global Oxaliplatin Revenue Forecast by Application (2021-2026)
5.2.3 Global Oxaliplatin Price Forecast by Application (2021-2026)
3 North America Oxaliplatin Market Facts & Figures
3.2 North America Oxaliplatin Sales Market Share by Company (2015-2020)
3.3 North America Oxaliplatin Sales Market Share by Type (2015-2020)
3.4 North America Oxaliplatin Sales Market Share by Application (2015-2020)
4 Europe Oxaliplatin Market Facts & Figures
4.2 Europe Oxaliplatin Sales Market Share by Company (2015-2020)
4.3 Europe Oxaliplatin Sales Market Share by Type (2015-2020)
4.4 Europe Oxaliplatin Sales Market Share by Application (2015-2020)
5 China Oxaliplatin Market Facts & Figures
5.2 China Oxaliplatin Sales Market Share by Company (2015-2020)
5.3 China Oxaliplatin Sales Market Share by Type (2015-2020)
5.4 China Oxaliplatin Sales Market Share by Application (2015-2020)
6 Japan Oxaliplatin Market Facts & Figures
6.2 Japan Oxaliplatin Sales Market Share by Company (2015-2020)
6.3 Japan Oxaliplatin Sales Market Share by Type (2015-2020)
6.4 Japan Oxaliplatin Sales Market Share by Application (2015-2020)
7 Southeast Asia Oxaliplatin Market Facts & Figures
7.2 Southeast Asia Oxaliplatin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Oxaliplatin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Oxaliplatin Sales Market Share by Application (2015-2020)
8 India Oxaliplatin Market Facts & Figures
8.2 India Oxaliplatin Sales Market Share by Company (2015-2020)
8.3 India Oxaliplatin Sales Market Share by Type (2015-2020)
8.4 India Oxaliplatin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Oxaliplatin Business
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Oxaliplatin Corporation Information
12.1.2 Sanofi-Aventis Oxaliplatin Business Overview and Total Revenue
12.1.3 Sanofi-Aventis Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi-Aventis Oxaliplatin Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 Yakult honsha
12.2.1 Yakult honsha Oxaliplatin Corporation Information
12.2.2 Yakult honsha Oxaliplatin Business Overview and Total Revenue
12.2.3 Yakult honsha Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Yakult honsha Oxaliplatin Products Offered
12.2.5 Yakult honsha Recent Development
12.3 Dr Reddy’s laboratories
12.3.1 Dr Reddy’s laboratories Oxaliplatin Corporation Information
12.3.2 Dr Reddy’s laboratories Oxaliplatin Business Overview and Total Revenue
12.3.3 Dr Reddy’s laboratories Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Dr Reddy’s laboratories Oxaliplatin Products Offered
12.3.5 Dr Reddy’s laboratories Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Oxaliplatin Corporation Information
12.4.2 Sun Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.4.3 Sun Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharmaceutical Oxaliplatin Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Teva
12.5.1 Teva Oxaliplatin Corporation Information
12.5.2 Teva Oxaliplatin Business Overview and Total Revenue
12.5.3 Teva Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Oxaliplatin Products Offered
12.5.5 Teva Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Oxaliplatin Corporation Information
12.6.2 Fresenius Kabi Oxaliplatin Business Overview and Total Revenue
12.6.3 Fresenius Kabi Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Fresenius Kabi Oxaliplatin Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Hospira
12.7.1 Hospira Oxaliplatin Corporation Information
12.7.2 Hospira Oxaliplatin Business Overview and Total Revenue
12.7.3 Hospira Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hospira Oxaliplatin Products Offered
12.7.5 Hospira Recent Development
12.8 Mylan
12.8.1 Mylan Oxaliplatin Corporation Information
12.8.2 Mylan Oxaliplatin Business Overview and Total Revenue
12.8.3 Mylan Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mylan Oxaliplatin Products Offered
12.8.5 Mylan Recent Development
12.9 Jiangsu Hengrui Medicine
12.9.1 Jiangsu Hengrui Medicine Oxaliplatin Corporation Information
12.9.2 Jiangsu Hengrui Medicine Oxaliplatin Business Overview and Total Revenue
12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Jiangsu Hengrui Medicine Oxaliplatin Products Offered
12.9.5 Jiangsu Hengrui Medicine Recent Development
12.10 Nanjing Pharmaceutical Factory
12.10.1 Nanjing Pharmaceutical Factory Oxaliplatin Corporation Information
12.10.2 Nanjing Pharmaceutical Factory Oxaliplatin Business Overview and Total Revenue
12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Products Offered
12.10.5 Nanjing Pharmaceutical Factory Recent Development
12.11 Jiangsu Aosaikang Pharmaceutical
12.11.1 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Corporation Information
12.11.2 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products Offered
12.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12.12 Qilu Pharmaceutical
12.12.1 Qilu Pharmaceutical Oxaliplatin Corporation Information
12.12.2 Qilu Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.12.3 Qilu Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Qilu Pharmaceutical Oxaliplatin Products Offered
12.12.5 Qilu Pharmaceutical Recent Development
12.13 Hisun Pharmaceutical
12.13.1 Hisun Pharmaceutical Oxaliplatin Corporation Information
12.13.2 Hisun Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.13.3 Hisun Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Hisun Pharmaceutical Oxaliplatin Products Offered
12.13.5 Hisun Pharmaceutical Recent Development
12.14 Lunan Pharmaceutical
12.14.1 Lunan Pharmaceutical Oxaliplatin Corporation Information
12.14.2 Lunan Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.14.3 Lunan Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Lunan Pharmaceutical Oxaliplatin Products Offered
12.14.5 Lunan Pharmaceutical Recent Development
12.15 Luoxin
12.15.1 Luoxin Oxaliplatin Corporation Information
12.15.2 Luoxin Oxaliplatin Business Overview and Total Revenue
12.15.3 Luoxin Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Luoxin Oxaliplatin Products Offered
12.15.5 Luoxin Recent Development
12.16 Halfsky Pharmacy
12.16.1 Halfsky Pharmacy Oxaliplatin Corporation Information
12.16.2 Halfsky Pharmacy Oxaliplatin Business Overview and Total Revenue
12.16.3 Halfsky Pharmacy Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Halfsky Pharmacy Oxaliplatin Products Offered
12.16.5 Halfsky Pharmacy Recent Development
12.17 YRPG
12.17.1 YRPG Oxaliplatin Corporation Information
12.17.2 YRPG Oxaliplatin Business Overview and Total Revenue
12.17.3 YRPG Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.17.4 YRPG Oxaliplatin Products Offered
12.17.5 YRPG Recent Development
12.18 Hainan Jinrui Pharmaceutical
12.18.1 Hainan Jinrui Pharmaceutical Oxaliplatin Corporation Information
12.18.2 Hainan Jinrui Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Products Offered
12.18.5 Hainan Jinrui Pharmaceutical Recent Development
12.19 Jari Pharmaceutical
12.19.1 Jari Pharmaceutical Oxaliplatin Corporation Information
12.19.2 Jari Pharmaceutical Oxaliplatin Business Overview and Total Revenue
12.19.3 Jari Pharmaceutical Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Jari Pharmaceutical Oxaliplatin Products Offered
12.19.5 Jari Pharmaceutical Recent Development
12.20 Chiatai Tianqing
12.20.1 Chiatai Tianqing Oxaliplatin Corporation Information
12.20.2 Chiatai Tianqing Oxaliplatin Business Overview and Total Revenue
12.20.3 Chiatai Tianqing Oxaliplatin Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Chiatai Tianqing Oxaliplatin Products Offered
12.20.5 Chiatai Tianqing Recent Development
13 Oxaliplatin Manufacturing Cost Analysis
13.1 Oxaliplatin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oxaliplatin
13.4 Oxaliplatin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oxaliplatin Distributors List
14.3 Oxaliplatin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oxaliplatin Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Oxaliplatin Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Oxaliplatin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Oxaliplatin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Oxaliplatin Players to Combat Covid-19 Impact
Table 8. Global Market Oxaliplatin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Oxaliplatin Sales (MT) by Region (2015-2020)
Table 10. Global Oxaliplatin Sales Market Share by Region (2015-2020)
Table 11. Global Oxaliplatin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Oxaliplatin Revenue Share by Region (2015-2020)
Table 13. Global Oxaliplatin Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Oxaliplatin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Oxaliplatin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Oxaliplatin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Oxaliplatin (MT) of Key Companies (2015-2020)
Table 18. Global Oxaliplatin Sales Share by Company (2015-2020)
Table 19. Global Oxaliplatin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Oxaliplatin Revenue Share by Company (2015-2020)
Table 21. Global Oxaliplatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2019)
Table 22. Global Oxaliplatin Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Oxaliplatin Manufacturing Sites and Area Served
Table 24. Manufacturers Oxaliplatin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Oxaliplatin Players
Table 27. Global Oxaliplatin Sales (MT) by Type (2015-2020)
Table 28. Global Oxaliplatin Sales Share by Type (2015-2020)
Table 29. Global Oxaliplatin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Oxaliplatin Price (MT) by Type (2015-2020)
Table 31. Global Oxaliplatin Sales Share by Type (2021-2026)
Table 32. Global Oxaliplatin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Oxaliplatin Revenue Share by Type (2021-2026)
Table 34. Global Oxaliplatin Price (MT) by Type (2021-2026)
Table 35. Global Oxaliplatin Sales (MT) by Application (2015-2020)
Table 36. Global Oxaliplatin Sales Share by Application (2015-2020)
Table 37. Global Oxaliplatin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Oxaliplatin Price (MT) by Application (2015-2020)
Table 39. Global Oxaliplatin Sales (MT) by Application (2021-2026)
Table 40. Global Oxaliplatin Sales Share by Application (2021-2026)
Table 41. Global Oxaliplatin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Oxaliplatin Revenue Share by Application (2021-2026)
Table 43. Global Oxaliplatin Price (MT) by Application (2021-2026)
Table 44. United States Oxaliplatin Sales (MT) by Company (2015-2020)
Table 45. United States Oxaliplatin Sales Market Share by Company (2015-2020)
Table 46. United States Oxaliplatin Sales (MT) by Type (2015-2020)
Table 47. United States Oxaliplatin Sales Market Share by Type (2015-2020)
Table 48. United States Oxaliplatin Sales (MT) by Application (2015-2020)
Table 49. United States Oxaliplatin Sales Market Share by Application (2015-2020)
Table 50. Europe Oxaliplatin Sales (MT) by Company (2015-2020)
Table 51. Europe Oxaliplatin Sales Market Share by Company (2015-2020)
Table 52. Europe Oxaliplatin Sales (MT) by Type (2015-2020)
Table 53. Europe Oxaliplatin Sales Market Share by Type (2015-2020)
Table 54. Europe Oxaliplatin Sales (MT) by Application (2015-2020)
Table 55. Europe Oxaliplatin Sales Market Share by Type (2015-2020)
Table 56. China Oxaliplatin Sales (MT) by Company (2015-2020)
Table 57. China Oxaliplatin Sales Market Share by Company (2015-2020)
Table 58. China Oxaliplatin Sales (MT) by Type (2015-2020)
Table 59. China Oxaliplatin Sales Market Share by Type (2015-2020)
Table 60. China Oxaliplatin Sales (MT) by Application (2015-2020)
Table 61. China Oxaliplatin Sales Market Share by Application (2015-2020)
Table 62. Japan Oxaliplatin Sales (MT) by Company (2015-2020)
Table 63. Japan Oxaliplatin Sales Market Share by Company (2015-2020)
Table 64. Japan Oxaliplatin Sales (MT) by Type (2015-2020)
Table 65. Japan Oxaliplatin Sales Market Share by Type (2015-2020)
Table 66. Japan Oxaliplatin Sales (MT) by Application (2015-2020)
Table 67. Japan Oxaliplatin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Oxaliplatin Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Oxaliplatin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Oxaliplatin Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Oxaliplatin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Oxaliplatin Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Oxaliplatin Sales Market Share by Application (2015-2020)
Table 74. India Oxaliplatin Sales (MT) by Company (2015-2020)
Table 75. India Oxaliplatin Sales Market Share by Company (2015-2020)
Table 76. India Oxaliplatin Sales (MT) by Type (2015-2020)
Table 77. India Oxaliplatin Sales Market Share by Type (2015-2020)
Table 78. India Oxaliplatin Sales (MT) by Application (2015-2020)
Table 79. India Oxaliplatin Sales Market Share by Application (2015-2020)
Table 80. Sanofi-Aventis Corporation Information
Table 81. Sanofi-Aventis Description and Business Overview
Table 82. Sanofi-Aventis Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi-Aventis Oxaliplatin Product
Table 84. Sanofi-Aventis Recent Development
Table 85. Yakult honsha Corporation Information
Table 86. Yakult honsha Description and Business Overview
Table 87. Yakult honsha Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Yakult honsha Oxaliplatin Product
Table 89. Yakult honsha Recent Development
Table 90. Dr Reddy's laboratories Corporation Information
Table 91. Dr Reddy's laboratories Description and Business Overview
Table 92. Dr Reddy's laboratories Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Dr Reddy's laboratories Oxaliplatin Product
Table 94. Dr Reddy's laboratories Recent Development
Table 95. Sun Pharmaceutical Corporation Information
Table 96. Sun Pharmaceutical Description and Business Overview
Table 97. Sun Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Sun Pharmaceutical Oxaliplatin Product
Table 99. Sun Pharmaceutical Recent Development
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Teva Oxaliplatin Product
Table 104. Teva Recent Development
Table 105. Fresenius Kabi Corporation Information
Table 106. Fresenius Kabi Description and Business Overview
Table 107. Fresenius Kabi Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Fresenius Kabi Oxaliplatin Product
Table 109. Fresenius Kabi Recent Development
Table 110. Hospira Corporation Information
Table 111. Hospira Description and Business Overview
Table 112. Hospira Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Hospira Oxaliplatin Product
Table 114. Hospira Recent Development
Table 115. Mylan Corporation Information
Table 116. Mylan Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Mylan Description and Business Overview
Table 118. Mylan Oxaliplatin Product
Table 119. Mylan Recent Development
Table 120. Jiangsu Hengrui Medicine Corporation Information
Table 121. Jiangsu Hengrui Medicine Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Jiangsu Hengrui Medicine Description and Business Overview
Table 123. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 124. Jiangsu Hengrui Medicine Recent Development
Table 125. Nanjing Pharmaceutical Factory Corporation Information
Table 126. Nanjing Pharmaceutical Factory Description and Business Overview
Table 127. Nanjing Pharmaceutical Factory Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 129. Nanjing Pharmaceutical Factory Recent Development
Table 130. Jiangsu Aosaikang Pharmaceutical Corporation Information
Table 131. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 132. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 134. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 135. Qilu Pharmaceutical Corporation Information
Table 136. Qilu Pharmaceutical Description and Business Overview
Table 137. Qilu Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Qilu Pharmaceutical Oxaliplatin Product
Table 139. Qilu Pharmaceutical Recent Development
Table 140. Hisun Pharmaceutical Corporation Information
Table 141. Hisun Pharmaceutical Description and Business Overview
Table 142. Hisun Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Hisun Pharmaceutical Oxaliplatin Product
Table 144. Hisun Pharmaceutical Recent Development
Table 145. Lunan Pharmaceutical Corporation Information
Table 146. Lunan Pharmaceutical Description and Business Overview
Table 147. Lunan Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Lunan Pharmaceutical Oxaliplatin Product
Table 149. Lunan Pharmaceutical Recent Development
Table 150. Luoxin Corporation Information
Table 151. Luoxin Description and Business Overview
Table 152. Luoxin Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Luoxin Oxaliplatin Product
Table 154. Luoxin Recent Development
Table 155. Halfsky Pharmacy Corporation Information
Table 156. Halfsky Pharmacy Description and Business Overview
Table 157. Halfsky Pharmacy Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Halfsky Pharmacy Oxaliplatin Product
Table 159. Halfsky Pharmacy Recent Development
Table 160. YRPG Corporation Information
Table 161. YRPG Description and Business Overview
Table 162. YRPG Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. YRPG Oxaliplatin Product
Table 164. YRPG Recent Development
Table 165. Hainan Jinrui Pharmaceutical Corporation Information
Table 166. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 167. Hainan Jinrui Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 169. Hainan Jinrui Pharmaceutical Recent Development
Table 170. Jari Pharmaceutical Corporation Information
Table 171. Jari Pharmaceutical Description and Business Overview
Table 172. Jari Pharmaceutical Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. Jari Pharmaceutical Oxaliplatin Product
Table 174. Jari Pharmaceutical Recent Development
Table . Chiatai Tianqing Corporation Information
Table . Chiatai Tianqing Description and Business Overview
Table . Chiatai Tianqing Oxaliplatin Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Chiatai Tianqing Oxaliplatin Product
Table . Chiatai Tianqing Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Oxaliplatin Distributors List
Table 183. Oxaliplatin Customers List
Table 184. Market Key Trends
Table 185. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 186. Key Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxaliplatin Product Picture
Figure 2. Global Oxaliplatin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oxaliplatin Market Share by Application in 2020 & 2026
Figure 6. Colorectal Cancer Examples
Figure 7. Stomach Cancer Examples
Figure 8. Ovarian Cancer Examples
Figure 9. Other Examples
Figure 10. Global Oxaliplatin Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Oxaliplatin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Oxaliplatin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Oxaliplatin Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Oxaliplatin Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Oxaliplatin Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Oxaliplatin Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Oxaliplatin Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Oxaliplatin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Oxaliplatin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Oxaliplatin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Oxaliplatin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Oxaliplatin Players Market Share by Revenue in Oxaliplatin 2015 & 2019
Figure 28. Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Oxaliplatin Revenue Share by Type (2015-2020)
Figure 30. Global Oxaliplatin Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Oxaliplatin Revenue Share by Application (2015-2020)
Figure 32. Global Oxaliplatin Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Oxaliplatin Sales Market Share by Type in 2019
Figure 34. United States Oxaliplatin Sales Market Share by Type in 2019
Figure 35. Europe Oxaliplatin Sales Market Share by Company in 2019
Figure 36. Europe Oxaliplatin Sales Market Share by Type in 2019
Figure 37. Europe Oxaliplatin Sales Market Share by Application in 2019
Figure 38. China Oxaliplatin Sales Market Share by Company in 2019
Figure 39. China Oxaliplatin Sales Market Share by Type in 2019
Figure 40. China Oxaliplatin Sales Market Share by Application in 2019
Figure 41. Japan Oxaliplatin Sales Market Share by Company in 2019
Figure 42. Japan Oxaliplatin Sales Market Share by Type in 2019
Figure 43. Japan Oxaliplatin Sales Market Share by Application in 2019
Figure 44. Southeast Asia Oxaliplatin Sales Market Share by Company in 2019
Figure 45. Southeast Asia Oxaliplatin Sales Market Share by Type in 2019
Figure 46. Southeast Asia Oxaliplatin Sales Market Share by Application in 2019
Figure 47. India Oxaliplatin Sales Market Share by Company in 2019
Figure 48. India Oxaliplatin Sales Market Share by Type in 2019
Figure 49. India Oxaliplatin Sales Market Share by Application in 2019
Figure 50. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Yakult honsha Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Dr Reddy's laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Jiangsu Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Nanjing Pharmaceutical Factory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Jiangsu Aosaikang Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Hisun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Lunan Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Luoxin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Halfsky Pharmacy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. YRPG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Hainan Jinrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Jari Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Chiatai Tianqing Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Key Raw Materials Price Trend
Figure 71. Manufacturing Cost Structure of Oxaliplatin
Figure 72. Manufacturing Process Analysis of Oxaliplatin
Figure 73. Oxaliplatin Industrial Chain Analysis
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Porter's Five Forces Analysis
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
卵巣がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Ovarian Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2382 million by 2025, from USD 1684.4 million in 2019. The Ovarian Cancer market r…- 癌用バイオマーカーの世界市場レポート2020 Market Analysis and Insights: Global Cancer Biomarkers Market The global Cancer Biomarkers market was valued at US$ 11710 million in 2019 and will reach US$ 18790 million by the end of 2026, growing at a CAGR of 6.9% during 2020-2026. Global Cancer Biomarkers Scope and Market Size The global Cancer …
- 卵巣がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ovarian Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovarian Cancer…
- 大腸がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.1% in the forecast period of 2020 to 2025 and will expected to reach USD 9118.8 million by 2025, from USD 8386.1 million in 2019. The Colorectal Cancer …
- 大腸がん診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Colorectal Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …